ECM
EagleClaw Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.38M | Sell |
7,585
-10
| -0.1% | -$4.45K | 0.5% | 52 |
|
|
2025
Q1 | $3.68M | Sell |
7,595
-35
| -0.5% | -$17K | 0.58% | 49 |
|
|
2024
Q4 | $3.07M | Buy |
7,630
+5
| +0.1% | +$2.01K | 0.49% | 59 |
|
|
2024
Q3 | $3.55M | Buy |
7,625
+200
| +3% | +$93K | 0.59% | 51 |
|
|
2024
Q2 | $3.48M | Sell |
7,425
-100
| -1% | -$46.9K | 0.63% | 47 |
|
|
2024
Q1 | $3.15M | Hold |
7,525
| – | – | 0.57% | 54 |
|
|
2023
Q4 | $3.06M | Sell |
7,525
-35
| -0.5% | -$14.2K | 0.64% | 51 |
|
|
2023
Q3 | $2.63M | Buy |
7,560
+120
| +2% | +$41.7K | 0.6% | 53 |
|
|
2023
Q2 | $2.62M | Hold |
7,440
| – | – | 0.6% | 56 |
|
|
2023
Q1 | $2.34M | Hold |
7,440
| – | – | 0.55% | 58 |
|
|
2022
Q4 | $2.15M | Hold |
7,440
| – | – | 0.52% | 64 |
|
|
2022
Q3 | $2.15M | Hold |
7,440
| – | – | 0.6% | 58 |
|
|
2022
Q2 | $2.1M | Hold |
7,440
| – | – | 0.57% | 60 |
|
|
2022
Q1 | $1.94M | Hold |
7,440
| – | – | 0.45% | 64 |
|
|
2021
Q4 | $1.63M | Buy |
+7,440
| New | +$1.63M | 0.36% | 65 |
|